Merck and Bristol-Myers Squibb brace for loss of lucrative d

New quarterly earnings reports offer insight into how the companies are preparing to potentially lose significant sources of revenue

Related Keywords

Bristol Myers Squibb , Christophers Boerner , Robertm Davis , , Wall Street , Harpoon Therapeutics , Aqua Business , Merck , Bristol Myers , Health , Medical , Dharma , Winrevair , Pembrolizumab , Apixaban , Keytruda , Merck Amp Co , Player , Business , Inance , Orphan Drugs , Antineoplastic Drugs , Schering Plough , Pharmaceutical Industry , Ancer Immunotherapy , Uartz ,